Pigmented progressive purpuric dermatosis https://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
https://en.wikipedia.org/wiki/Pigmented_purpuric_dermatosis
☆ AI Dermatology — Free ServiceKwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.  - Schamberg disease ― indoda eneminyaka engama-26 ubudala enebala elingabonakaliyo kunye ne‑telangiectasia emlenzeni. 
relevance score : -100.0%
References Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260
 Pigmented Purpuric Dermatoses: A Complete Narrative Review 34070260 NIH
Pigmented purpuric dermatoses (PPD) liqela leemeko zolusu eziphawulwe ziindawo ezincinci zokopha phantsi kwesikhumba ngenxa yokudumba kwecapillary. I-PPD iqala ngokubomvu ukuya kumabala amfusa athi kamva ajike abe bugolide‑mdaka njengoko i‑hemosiderin iphinda ifakwa.
Pigmented purpuric dermatoses (PPD) include several skin diseases characterized by multiple petechial hemorrhage as consequence of capillaritis. PPD generally present with red to purple macules that progressively evolve to golden-brown color as the hemosiderin is reabsorbed.
 Schamberg Disease 32809367
 Schamberg Disease 32809367 NIH
Schamberg disease lolona hlobo luxhaphakileyo lwe pigmented purpuric dermatoses (PPDs) , eziziimeko zolusu ezingapelliyo eziphawulwa ngamabala amancinci abomvu okanye amfusa, kunye nokwanda kombala wolusu (amabala amdaka, obomvu, okanye omthubi) . IiPPD zihlelwa ngokweendidi ezintlanu: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura, eczematoid-like purpura of Doucas and Kapetanakis. Schamberg disease (SD) ikwabizwa ngokuba yi progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive, Schamberg's purpura. Ichaphazela kakhulu amadoda kwaye ibonakala kwimilenze esezantsi, kodwa ingenzeka nasemathangeni, ezimpundu, esiqwini, okanye ezingalweni.
Schamberg disease represents the most common type of pigmented purpuric dermatoses (PPDs), a chronic, benign, cutaneous eruptions characterized by petechiae, purpura, and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into five clinical entities: Schamberg's purpura, Majocchi purpura, lichen aureus, Gougerot-Blum purpura and, eczematoid-like purpura of Doucas and Kapetanakis. Schamber disease (SD) has also been called: progressive pigmentary dermatosis of Schamberg, purpura pigmentosa progressive and, Schamberg's purpura. It is commonly seen in males and mainly affects the tibial regions, and could involve thighs, buttocks, trunk, or upper extremities.
 Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156
 Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis 26273156 NIH
Ulwazi malunga nezigulane ezili-113 ezine‑PPD zahlaziywa, kubandakanywa ne‑38 ezafumana i‑biopsy yesikhumba kolu phonotongo. Olu hlobo luqhelekileyo lweklinikhi yayisisifo sikaSchamberg (60.5%). Ezinye iimeko ezisecaleni kwe‑PPD zaziyi‑ukuxineka kwegazi (hypertension) (15.8%), isifo sikashukela (diabetes) (10.5%), kunye nabanye. Imbali yonyango ibonakalise i‑statins (13.2%), i‑beta blockers (10.5%), kunye nabanye. Izinto ezinokuthi zixhunywe kwi‑PPD zibandakanya ukuhlaselwa kokuphefumla okuphezulu kwakutshanje (recent upper respiratory infection) (5.3%), ukuma ixesha elide okubangela uxinzelelo oluphezulu lwe‑orthostatic (high orthostatic pressure due to prolonged standing) (2.6%), kunye nokuzivocavoca okunzima (strenuous exercise) (2.6%). Unyango lwanikezelwa kwizigulane ezili-36 (94.7%) – i‑antihistamines ezithathwa ngomlomo (oral antihistamines), i‑pentoxifylline, i‑steroids ezisetyenziselwa ukuxubha (topical steroids) kunye/nokuba i‑phototherapy.
Information on 113 patients with PPD was analyzed, and 38 subjects with skin biopsy were included for this study. Schamberg's disease was the most frequent clinical type (60.5%). Concomitant diseases included hypertension (15.8%), diabetes (10.5%), and others. Associated medication histories included statins (13.2%), beta blockers (10.5%), and others. Possibly associated etiologic factors were recent upper respiratory infection (5.3%), high orthostatic pressure due to prolonged standing (2.6%), and strenuous exercise (2.6%). A total of 36 patients (94.7%) were treated with one or more treatment methods, including oral antihistamines, pentoxifylline, topical steroids, and/or phototherapy.
 
○ Unyango ― OTC Amachiza
#OTC steroid ointment
#Hydrocortisone ointment
#Hydrocortisone cream